These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia. Rishi MT; Selvaraju V; Thirunavukkarasu M; Shaikh IA; Takeda K; Fong GH; Palesty JA; Sanchez JA; Maulik N Microvasc Res; 2015 Jan; 97():181-8. PubMed ID: 25446011 [TBL] [Abstract][Full Text] [Related]
24. Role of endothelial Raptor in abnormal arteriogenesis after lower limb ischaemia in type 2 diabetes. Liu T; Zhang J; Chang F; Sun M; He J; Ai D Cardiovasc Res; 2024 Sep; 120(10):1218-1234. PubMed ID: 38722901 [TBL] [Abstract][Full Text] [Related]
25. BuZangTongLuo decoction improved hindlimb ischemia by activating angiogenesis and regulating gut microbiota in diabetic mice. Zheng J; Chen M; Ye C; Sun X; Jiang N; Zou X; Yang H; Liu H J Ethnopharmacol; 2020 Feb; 248():112330. PubMed ID: 31654796 [TBL] [Abstract][Full Text] [Related]
26. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433 [TBL] [Abstract][Full Text] [Related]
27. Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis. Tepeköylü C; Wang FS; Kozaryn R; Albrecht-Schgoer K; Theurl M; Schaden W; Ke HJ; Yang Y; Kirchmair R; Grimm M; Wang CJ; Holfeld J J Thorac Cardiovasc Surg; 2013 Oct; 146(4):971-8. PubMed ID: 23395097 [TBL] [Abstract][Full Text] [Related]
28. PGC-1α induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle. Rowe GC; Raghuram S; Jang C; Nagy JA; Patten IS; Goyal A; Chan MC; Liu LX; Jiang A; Spokes KC; Beeler D; Dvorak H; Aird WC; Arany Z Circ Res; 2014 Aug; 115(5):504-17. PubMed ID: 25009290 [TBL] [Abstract][Full Text] [Related]
29. HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia. Sachdev U; Cui X; Tzeng E J Vasc Surg; 2013 Aug; 58(2):460-9. PubMed ID: 23414695 [TBL] [Abstract][Full Text] [Related]
30. Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions. Huang PH; Chen JW; Lin CP; Chen YH; Wang CH; Leu HB; Lin SJ Cardiovasc Diabetol; 2012 Aug; 11():99. PubMed ID: 22894755 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of myeloperoxidase increases revascularization and improves blood flow in a diabetic mouse model of hindlimb ischaemia. Weihrauch D; Martin DP; Jones D; Krolikowski J; Struve J; Naylor S; Pritchard KA Diab Vasc Dis Res; 2020; 17(3):1479164120907971. PubMed ID: 32223319 [TBL] [Abstract][Full Text] [Related]
33. Simvastatin pretreatment enhances ischemia-induced neovascularization and blood flow recovery in streptozotocin-treated mice. Huang PH; Chen JY; Chen CY; Chen JW; Lin SJ; Shih CC J Vasc Surg; 2016 Oct; 64(4):1112-1120.e1. PubMed ID: 26830691 [TBL] [Abstract][Full Text] [Related]
34. Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease. Kundu N; Domingues CC; Chou C; Ahmadi N; Houston S; Jerry DJ; Sen S J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28365567 [TBL] [Abstract][Full Text] [Related]
35. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. Yan J; Tie G; Park B; Yan Y; Nowicki PT; Messina LM J Vasc Surg; 2009 Dec; 50(6):1412-22. PubMed ID: 19837544 [TBL] [Abstract][Full Text] [Related]
36. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice. Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591 [TBL] [Abstract][Full Text] [Related]
37. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis. Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783 [TBL] [Abstract][Full Text] [Related]
38. BubR1 insufficiency impairs angiogenesis in aging and in experimental critical limb ischemic mice. Okadome J; Matsumoto T; Yoshiya K; Matsuda D; Tamada K; Onimaru M; Nakano K; Egashira K; Yonemitsu Y; Maehara Y J Vasc Surg; 2018 Aug; 68(2):576-586.e1. PubMed ID: 28974341 [TBL] [Abstract][Full Text] [Related]
39. Endothelial-specific transgenesis of TNFR2 promotes adaptive arteriogenesis and angiogenesis. Luo Y; Xu Z; Wan T; He Y; Jones D; Zhang H; Min W Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1307-14. PubMed ID: 20395596 [TBL] [Abstract][Full Text] [Related]
40. Tumor suppressor protein p53 negatively regulates ischemia-induced angiogenesis and arteriogenesis. Pfaff MJ; Mukhopadhyay S; Hoofnagle M; Chabasse C; Sarkar R J Vasc Surg; 2018 Dec; 68(6S):222S-233S.e1. PubMed ID: 30126780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]